The French drugmaker on Monday announced progress on a deal to sell 50% of its over-the-counter division to Clayton Dubilier ...

Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...

Under the proposed deal, the PE firm would take a controlling 50% stake in Sanofi’s Opella unit, with state-owned Bpifrance ...

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

As part of new agreements announced at the 7th edition of the Global Health Forum, Saudi Arabia signed deals to localize the ...

Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French ...

The CDC investigates potential bird flu infections in Washington farm workers. Baxter seeks to restore dialysis patient ...

Sanofi and Sudair Pharma Company (SPC) have joined forces to establish a state-of-the-art manufacturing facility within the ...

US plane maker Boeing is heading into a busy week, with investors watching developments closely around its costly labour ...

Thursday’s agreement with Orano Med is the second in as many months. Sanofi in September made its first foray into the ...

Weeks after penning a $110 million upfront deal with Orano Med for the global rights to a neuroendocrine tumor treatment, ...

Recent health news highlights include a CDC team assessing bird flu in Washington state farm workers, CVS's leadership change ...